X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Tjoapack expands into the US with the acquisition of Pharma Packaging Solutions

Content Team by Content Team
26th October 2021
in Packaging & Logistic, Press Statements
Tjoapack expands pre-filled pharma packaging

Tjoapack, a Netherlands-based contract packaging organisation serving the pharmaceutical industry, has acquired US-based Pharma Packaging Solutions, a leading healthcare packaging services business based in Clinton, TN. PPS provides commercial packaging and other, complementary services such as cold chain storage, stability and product retain services to a variety of pharmaceutical and medical device industry customers.

“Tjoapack’s acquisition of PPS creates an opportunity to build a new global leader in contract packaging and supply chain services for the pharmaceutical market. The acquisition supports Tjoapack’s growth strategy and is indicative of our commitment to customers,” said Dexter Tjoa, CEO of Tjoapack. “Both companies are known in the market for having a nimble, customer-centric mindset that translates into high service quality and flexibility in providing tailored solutions to complex client needs. Having operations in both the US and Europe will ensure that our customers’ products are available to patients that need them anywhere and anytime.”

Reid Lederer, President of PPS, added, “By joining Tjoapack, Pharma Packaging Solutions will have access to resources and an extended global market presence to accelerate future growth. An important benefit of the business combination will be investments by Tjoapack to enhance PPS’s operational efficiency and capabilities, including the addition of automated packaging and labeling capabilities for injectable products. Together, the two companies will emerge as a leading, trusted provider of packaging and other value-added services to healthcare industry clients around the globe.”

Tjoapack’s acquisition of PPS was funded by Ampersand Capital Partners (“Ampersand”) which first invested in the Company in 2020. With support from Ampersand, Tjoapack is nearing the completion of a major facility expansion to substantially increase packaging capacity for both oral solid and parenteral drug products.

ABOUT TJOAPACK

Founded in 1989, Tjoapack is a contract packager of medicines that provides innovative, flexible service to clients across five continents and 45 countries. With currently 19 packaging lines, the company offers primary, secondary and unit dose packaging for oral solid dose blister packs, wallets and bottles. Tjoapack also provides automated labelling and packaging of injectable products, along with complementary supply chain services. Tjoapack’s 120,000 square foot facility is strategically located near the ports of Rotterdam and Antwerp, serving as a gateway to the European market.

ABOUT PHARMA PACKAGING SOLUTIONS

Pharma Packaging Solutions was founded in 1998 as a division of Carton Services, Inc., a supplier of folding cartons to the pharmaceutical, food and consumer packaged goods industries. Operating from a 110,000 square foot facility in Clinton, TN, PPS serves a variety of healthcare industry customers with contract packaging and related services.

ABOUT AMPERSAND CAPITAL PARTNERS

Founded in 1988, Ampersand is a middle market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors.

Previous Post

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

Next Post

Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines

Related Posts

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging
Europe

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

3rd March 2023
Canada's National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero
Manufacturing

Canada’s National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero

22nd February 2023
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
News

DoKaSch Temperature Solutions and ANA sign master rental agreement

21st February 2023
Amyris and Immunitybio Complete Joint Venture for Next Generation Covid-19 RNA Vaccine
Drug Development

Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China

21st February 2023
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
Clinical Trials

Labcorp Unveils New Name for Future Independent Clinical Development Business – Fortrea

21st February 2023
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
IPR Data Management

Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

21st February 2023
Next Post
The UK begins the biggest ever immunization program

Enesi Pharma inks pact with NIH to evaluate ImplaVax-enabled flu vaccines

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In